Acute Respiratory Distress Syndrome (ARDS) Therapeutics Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
The global acute respiratory distress syndrome therapeutics market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2023-2029). A number of government information initiatives are underway to educate the public about the various diagnoses and treatments accessible. Several items with superior powers have been launched by major market businesses. Hospitals/Clinics are well equipped with advanced technological equipment for surgical procedures and improved treatments and the hospital segment is witnessing rapid growth, owing to the growing number of hospital admission with the ARDS therapeutics, the increasing number of patient pools, and the launch of new products by the market players are expected to continue over the forecast period, and thus, driving growth in the segment.
The increasing number of hospitals
by private players is also expected to propel the growth of the market. For
instance, in April 2022, the Food and Drug Administration (FDA) approved Direct
Biologics to proceed with a Landmark Phase 3 clinical trial using its
investigation EV Drug ExoFlow to treat acute respiratory distress syndrome
(ARDS) therapeutic. For instance, in January 2022, Veru declared that
Sabizabulin has been given a fast-track designation by the FDA for the
treatment of hospitalized COVID-19 patients who are at high risk of developing
acute respiratory distress syndrome.
To Request a Sample of our Report on Acute Respiratory
Distress Syndrome (ARDS) Therapeutics Market: https://www.omrglobal.com/request-sample/acute-respiratory-distress-syndrome-ards-therapeutics-market
Market Coverage
•
The market number available for – 2023-2029
•
Base year- 2022
•
Forecast period- 2023-2029
Segment Covered-
·
By Type
·
By Drug Class
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Therabron Therapeutics, Inc, Serendex Pharmaceuticals A/S, Silence Therapeutics
Plc, Histocell S.L., Altor BioScience Corporation, and others.
Acute Respiratory Distress Syndrome Therapeutics Market Report Segment
By Type
•
Methylprednisolone
•
Hydrocortisone
•
Calf Pulmonary Surfactant for Injection
•
Others
By Drug Class
•
Corticosteroids
•
Antimicrobials
•
Bronchodilators
•
Other Medications
By Application
•
In-Patient
•
Out-Patient
A
full Report of Acute Respiratory
Distress Syndrome (ARDS) Therapeutics Marketis
Available @ https://www.omrglobal.com/industry-reports/acute-respiratory-distress-syndrome-ards-therapeutics-market
Acute respiratory distress syndrome therapeutics
Market Report Segment by Region
North America
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East and Africa
Company
Profiles
·
Altor BioScience Corp.
·
Athersys, Inc
·
Faron Pharmaceuticals Oy
·
FirstString Research, Inc.
·
FRESENIUS SE & CO. KGAA
·
GETINGE AB
·
GILEAD SCIENCES INC.
·
GlaxoSmithKline Plc
·
Histocell S.L.
·
Medtronic, Inc.
·
NIPRO and PFIZER INC.
·
Phylogica Ltd.
·
Serendex Pharmaceuticals A/S
·
Silence Therapeutics plc
·
Terumo Corp.
·
Therabron Therapeutics, Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/acute-respiratory-distress-syndrome-ards-therapeutics-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment